Sunshine Biopharma repurchases and cancels warrants for ~21.6M shares for $3.14M total

Sunshine Biopharma Inc.

Bought back May 2023 warrants for 11,904,762 shares from Armistice Capital for $2,361,596; warrants cancelled.
Bought back April 2022 warrants for 9,725,690 shares from holders for $0.08 each ($778,055 total); cancelled.
Armistice Capital waived variable-rate transaction prohibition under the May 2023 securities purchase agreement.
Combined repurchase eliminates potential dilution from ~21.6M shares; cash outlay ~$3.14M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.